NEWS COMMENTARY

Memphis Meats looks to commercialize cell-based meat with $161 million Series B funding

Published:
January 24, 2020
Coverage:
Emerging Ecosystems in Agrifood and Health More...
Activities:
Investment
Very important

This funding round was led by Temasek, SoftBank Group, and Norwest, with participation from several other investors, including previous ones like Cargill and Tyson Foods. Memphis is the first company in the fast-growing cell-based meat space to raise Series B funding. With about $180 million in funding raised to date, the company hopes to build a pilot production facility and further the commercialization of clean meat products in coming years. Despite this influx of cash, Memphis still has an arduous task in terms of developing cost-efficient serum-free media to achieve cost parity. Nevertheless, cell-based meat will be an important part of the future of proteins, opening up multiple investment and partnership opportunities for clients.

For the original news article, click here .


Further Reading

Qualitas Health raises $10 million to expand to the alternative protein market

News Commentary | January 13, 2021

The round was led by PeakBridge VC and joined by Minrav, Arancia, and other investors. Qualitas Health grows algae in open raceway ponds to produce omega‑3 supplements (under the iwi brand). The company will use the funding to further its sales, research, and clinical testing efforts and accelerate ... Not part of subscription

BlueNalu looks to commercialize cell-based seafood with $60 million funding

News Commentary | January 22, 2021

Led by Rage Capital, this convertible note financing will help BlueNalu realize its commercialization plans, including the completion of a 40,000 ft2 pilot facility in the U.S. This funding round also places BlueNalu as the front‑runner in the cell‑based seafood space. The company's first product is... To read more, click here.

TerViva's $54 million will bring pongamia-derived ingredients to market

News Commentary | May 24, 2021

The funding comes from several industry executives and will be used by TerViva to commercialize its Pongamia‑derived oil and new protein product. In addition to the $54 million, TerViva expects to raise $24 million in equity and debt capital this quarter. TerViva has teamed up with Danone to create ... Not part of subscription